3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Thoracic
1
Conditions
Prostatic Neoplasms
1629
Carcinoma, Renal Cell
497
Urinary Bladder Neoplasms
462
Carcinoma, Transitional Cell
237
Breast Neoplasms
227
Kidney Neoplasms
215
Neoplasms
193
Carcinoma, Non-Small-Cell Lung
173
Colorectal Neoplasms
171
Ovarian Neoplasms
163
Melanoma
163
Neoplasm Metastasis
143
Lung Neoplasms
130
Non-Muscle Invasive Bladder Neoplasms
105
Pancreatic Neoplasms
102
Stomach Neoplasms
98
Uterine Cervical Neoplasms
92
Squamous Cell Carcinoma of Head and Neck
86
Endometrial Neoplasms
84
Carcinoma, Hepatocellular
79
Sarcoma
75
Esophageal Neoplasms
70
Head and Neck Neoplasms
69
Adenocarcinoma
67
Triple Negative Breast Neoplasms
65
Colonic Neoplasms
53
Testicular Neoplasms
52
Disease
48
Urologic Neoplasms
47
Wilms Tumor
46
Interventions
Morphine
1
Microscopy, Confocal
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Nephrolithiasis
×
Genitourinary
×
1 year
×
Clear all
NCT06349668
2026-02-05
SMILe
University Hospital, Linkoeping
Phase 3
Recruiting
220 enrolled
NCT02276924
2025-12-24
UROVISIO
Lille Catholic University
Phase NA
Completed
29 enrolled
NCT07171190
2025-12-19
TACTICAL1
University of Cambridge
Phase NA
Recruiting
6,272 enrolled